Plain-English translation of NCT06156670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—a collection of patient information and outcomes—for people who have had a stroke of unknown origin and have been diagnosed with a patent foramen ovale (a small opening between the chambers of the heart). Researchers are tracking patients who receive an endovascular closure procedure, which is a minimally invasive surgery to seal this opening using a small device threaded through blood vessels.
About one-third of strokes happen without a clear cause, and a patent foramen ovale may play a role in some of these cases. By gathering real-world data from patients undergoing closure procedures, researchers hope to better understand how effective this treatment is and how it affects long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would undergo the endovascular closure procedure (a minimally invasive surgery to close your heart opening) and then be followed by the research team to track your health outcomes over time. The registry collects information about your procedure, recovery, and long-term results to help doctors understand how well this treatment works for preventing future strokes. Follow-up visits and check-ins would be part of your participation.
AI-generated summary from trial data · Jul 22, 2026 · Not medical advice
Russia
Sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Enrollment target
~700 participants
Started
December 2023
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Andrey Tereschenko
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.